Single Dose Study to Assess the Safety, Tolerability, Concentration in Body and Effect of BAF312

This study has been completed.
Sponsor:
Information provided by:
Novartis
ClinicalTrials.gov Identifier:
NCT00422175
First received: January 11, 2007
Last updated: November 28, 2007
Last verified: November 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2007
  Estimated Primary Completion Date: No date given